Baron and Budd Announces Qualifications Needed to Participate in the GranuFlo Lawsuit
Baron and Budd offers information concerning the qualifications for the GranuFlo lawsuit
LOS ANGELES (PRWEB) August 09, 2013
An alleged link between heart attacks and GranuFlo, a component of dialysis treatments, has been found. According to the U.S. Food and Drug Administration’s (FDA) Class 1 recall of GranuFlo on March 29, 2012, “Inappropriate prescription of these products can lead to a high serum bicarbonate level in patients undergoing hemodialysis. This may contribute to metabolic alkalosis, which is a significant risk factor associated with low blood pressure, hypokalemia, hypoxemia, hypercapnia and cardiac arrhythmia, which, if not appropriately treated, may culminate in cardiopulmonary arrest.” http://www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm309990.htm
In an effort to respond to the allegations of these severe health risks, Baron and Budd has begun to assist patients who believe themselves injured by detailing the qualifications necessary for a potential GranuFlo lawsuit case.
Patients who have suffered heart attacks while undergoing dialysis are encouraged to contact the lawyers at Baron and Budd for a free consultation. If you or someone you know has been seriously injured while undergoing dialysis, there is a chance that GranuFlo was used as a component of the dialysis treatment.
The FDA’s class 1 recall began after evidence that GranuFlo and its sister drug, NaturaLyte, have a potential link to heart attacks. GranuFlo is produced by Fresenius Medical Care (FMD), the top manufacturer of dialysis products and services. GranuFlo is also believed to have been used in many hemodialysis treatments at non-Fresenius clinics as well. At this time, GranuFlo is still on the market.
To contact Baron and Budd’s GranuFlo lawyers, please call 1.866.844.4556 or email info(at)baronbudd.com. To learn more about GranuFlo lawyers and the law office of Baron and Budd, please visit: http://baronandbudd.com/areas-of-practice/pharmaceuticals/GranuFlo-lawyer/.
The GranuFlo lawyers at Baron and Budd are dedicated to “Protecting What’s Right.” With an impressive record of success in pharmaceutical class actions, lawyers at the national law firm of Baron and Budd are committed to confronting negligent companies and helping the injured receive compensation.
For the original version on PRWeb visit: http://www.prweb.com/releases/2013/8/prweb11011274.htm